Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
106.91
-1.46 (-1.35%)
May 29, 2026, 4:00 PM EDT - Market closed
Insmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 819.56 | 606.42 | 363.71 | 305.21 | 245.36 | 188.46 | |
Revenue Growth (YoY) | 115.09% | 66.73% | 19.17% | 24.39% | 30.19% | 14.63% |
Cost of Revenue | 149.08 | 122.94 | 85.74 | 65.57 | 55.13 | 44.15 |
Gross Profit | 670.48 | 483.49 | 277.97 | 239.64 | 190.23 | 144.31 |
Selling, General & Admin | 800.88 | 701.17 | 461.12 | 344.5 | 265.78 | 234.27 |
Depreciation & Amortization Expenses | 6.82 | 6 | 5.05 | 5.05 | 5.05 | 5.05 |
Research & Development | 828 | 771.09 | 598.37 | 571.01 | 397.52 | 272.74 |
Other Operating Expenses | 186.73 | 251.99 | 91.68 | 28.7 | -20.8 | 7.33 |
Total Operating Expenses | 1,822 | 1,730 | 1,156 | 949.26 | 647.55 | 519.4 |
Operating Income | -1,152 | -1,247 | -878.25 | -709.63 | -457.32 | -375.09 |
Interest Income | 58.79 | 60.66 | 53.31 | 42.13 | 11.08 | 0.17 |
Interest Expense | -82.31 | -83.8 | -84.91 | -81.69 | -26.45 | -40.47 |
Other Non-Operating Income (Expense) | -2.71 | -1.84 | -0.21 | 2.18 | -7.47 | -21.02 |
Total Non-Operating Income (Expense) | -26.23 | -24.98 | -31.81 | -37.39 | -22.83 | -61.32 |
Pretax Income | -1,178 | -1,272 | -910.07 | -747.01 | -480.15 | -436.41 |
Provision for Income Taxes | 5.58 | 5.03 | 3.71 | 2.56 | 1.38 | -1.76 |
Net Income | -1,184 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Net Income to Common | -1,184 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Shares Outstanding (Basic) | 208 | 199 | 164 | 140 | 123 | 112 |
Shares Outstanding (Diluted) | 208 | 199 | 164 | 140 | 123 | 112 |
Shares Change (YoY) | 20.61% | 21.32% | 16.81% | 14.14% | 9.74% | 14.86% |
EPS (Basic) | -5.75 | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
EPS (Diluted) | -5.75 | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
Shares Outstanding | 216.52 | 214.26 | 179.38 | 147.98 | 135.65 | 118.74 |
Free Cash Flow | -921.64 | -967.58 | -705.81 | -549.54 | -410.32 | -370.59 |
Free Cash Flow Per Share | -4.44 | -4.86 | -4.30 | -3.91 | -3.33 | -3.31 |
Gross Margin | 81.81% | 79.73% | 76.43% | 78.52% | 77.53% | 76.57% |
Operating Margin | -140.56% | -205.59% | -241.47% | -232.51% | -186.39% | -199.03% |
Profit Margin | -144.44% | -210.54% | -251.24% | -245.59% | -196.26% | -230.63% |
FCF Margin | -112.45% | -159.55% | -194.06% | -180.05% | -167.23% | -196.64% |
EBITDA | -1,131 | -1,228 | -864.53 | -696.34 | -445.03 | -359.83 |
EBITDA Margin | -137.99% | -202.43% | -237.70% | -228.15% | -181.38% | -190.93% |
EBIT | -1,152 | -1,247 | -878.25 | -709.63 | -457.32 | -375.09 |
EBIT Margin | -140.56% | -205.59% | -241.47% | -232.51% | -186.39% | -199.03% |
Effective Tax Rate | -0.47% | -0.40% | -0.41% | -0.34% | -0.29% | 0.40% |